Eucalyptol

Eucalyptol

SCHEMBL17836873

CC1(C)O[C@]2(C)CC[C@@H]1CC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 1.00
MAPT P10636 1/20 1.00
TSHR P16473 1/20 1.00
MAPK1 P28482 1/20 1.00
RECQL P46063 1/20 1.00
SYNJ2 O15056 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eucalyptol SCHEMBL1004746 1.00 LMNA (1.00) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL19622 1.00 LMNA (1.00) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL41020 1.00 LMNA (1.00) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL21462060 0.97 LMNA (0.95) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL1492188 0.93 LMNA (0.86) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL6122971 0.87 LMNA (0.75) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL17022815 0.87 MAPK1 (0.75) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL19474967 0.85 LMNA (0.72) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL9791399 0.85 MAPK1 (0.72) LMNAMAPTTSHRMAPK1RECQL
Eucalyptol SCHEMBL5324431 0.85 LMNA (0.72) LMNAMAPTTSHRMAPK1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214303-B1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2026-05-06 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
US-12522786-B2 Organic compounds GIVAUDAN SA (CH) 2026-01-13 US claimed
US-20240016711-A1 Perfume Compositions GIVAUDAN SA (CH) 2024-01-18 US claimed
US-20240016712-A1 Perfume Compositions GIVAUDAN SA (CH) 2024-01-18 US claimed
US-20230399590-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS SA, GIVAUDAN (CH) 2023-12-14 US claimed
US-20230365901-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2023-11-16 US claimed
US-20230212483-A1 Improvements in or Relating to Organic Compounds GIVAUDAN SA (CH) 2023-07-06 US claimed
US-20230151305-A1 FRAGRANCE COMPOSITION SA, GIVAUDAN (CH) 2023-05-18 US claimed
US-11364184-B2 Perfume compositions GIVAUDAN SA (CH) 2022-06-21 US claimed
US-10982173-B2 Fragrance compositions GIVAUDAN SA (CH) 2021-04-20 US claimed
US-20190336413-A1 Perfume Compositions GIVAUDAN SA (CH) 2019-11-07 US claimed
US-20190218476-A1 FRAGRANCE COMPOSITIONS GIVAUDAN SA (CH) 2019-07-18 US claimed
EP-3155084-B1 DISHWASHER DETERGENT FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2018-11-07 EP claimed
EP-4214303-B1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2026-05-06 EP disclosed
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US disclosed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US disclosed
US-20170081619-A1 Dishwasher Detergent Fragrance Composition GIVAUDAN S.A. (CH) 2017-03-23 US disclosed
WO-2016097024-A1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2016-06-23 WO disclosed
EP-3034064-A1 Perfume composition Givaudan Schweiz AG (CH) 2016-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 LMNA 1922/4885MAPT 1016/4885TSHR 2858/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 LMNA 1900/4885MAPT 4309/4885TSHR 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.